0
Novo Nordisk A/S, Soeborg, Denmark The three anthropometric measures were highly correlated (r=0.82 for SAD and WC; r=0.74 for 1 3 8 SAD and BMI; r=0.76 for WC and BMI). However, there was a systematic difference between the Associations between anthropometric measures and cardiometabolic health 1 5 0 BMI, WC and SAD were associated with all markers of an adverse metabolic phenotype (Table 2) . indicating that they explained the variation in cardiometabolic measures equally well (Table 2) .
Furthermore, there were no differences between the variance explained by SAD-to-height ratio and WC-to-height ratio (Supplemental table 1) and the variation explained by these measures did not
from those of SAD and WC alone. The ability of anthropometric measurements to identify individuals with metabolic syndrome We found that BMI, WC and SAD were overall fair in their ability to identify individuals with 1 6 0 metabolic syndrome markers above the IDF cut-offs after adjustments for age, sex, smoking and 1 6 1 study and there was no differences between BMI, WC and SAD in their ability to identify these 1 6 2 individuals (Table 3) . However, in the unadjusted analysis WC and SAD performed slightly better
than BMI in identifying individuals with metabolic syndrome markers above the IDF cut-offs for 1 6 4 glucose >6.1 mmol/L, triglycerides, systolic and diastolic blood pressure, compared to BMI ( Table   1  6  5 3). Using WC-to-height ratio and SAD-to-height ratio for identification of individuals with 1 6 6 metabolic syndrome markers above the IDF cut-offs did not show any differences between the two 1 6 7 (Supplementary table 2) or between these and SAD and WC alone. Differences between sexes and between BMI categories
Contrary to the differences observed between the three anthropometric measures in the unadjusted 1 7 1 models in men and women combined, there were no differences between BMI, WC and SAD in 1 7 2 men or women alone (Supplementary table 3) . However, we observed sex differences in the IDF cut-offs. The prediction was generally better in women than in men especially for glucose >6.1
mmol/L, HDL and sBP in the unadjusted models and the prediction for sBP was still better for both SAD and BMI after adjustment (Supplementary table 3).
7 7
As for the models for the entire population, WC and SAD had a better ability to identify individuals In the present study, we found distinct differences between SAD and WC over the BMI range, identification ability of the anthropometric measures. Earlier studies comparing SAD and WC show conflicting results and only examine a few risk
markers at a time whereas our study measures multiple cardiometabolic risk markers giving a more
complete metabolic overview. Similar to other studies our study show no difference between SAD
and WC as markers of cardiometabolic health (19, 20) . One study in 826 elderly Dutch men and
women report differences in correlations with markers of insulin resistance, dyslipidemia, and blood
pressure between SAD or WC both above and below the age of 65 years of age but no consistently with respect to which was the better (19). However, other studies have shown that SAD is a show a minor benefit of SAD compared to WC (2,22). One study showed that SAD was a better 2 0 2 predictor of insulin resistance compared to WC in high-risk group of 59 moderately obese men (21),
whereas a study including 885 men and women only found that SAD was marginally better in identifying elevated cardiometabolic risk in men with SAD compared to WC, but no difference
For hard endpoints such as CVD, SAD has been shown to be a better predictor than WC (4,9). One 2 0 9 study showed that SAD >25 cm was the only anthropometric measurement associated with major
CVD events in patients with T2D (4). Similary, a different study showed that SAD was the only 2 1 1 measure that significantly predicted CVD in men, but not in women (9). This study also showed 2 1 2 that SAD could predict CVD after adjustments for traditional biomarkers such as total-and HDL production and FFA release into circulation. In the present study, we included inflammatory
cytokines in order to elucidate whether SAD was really, a better predictor of adverse metabolic
cytokine production associated with increased VAT. We did not find that SAD and WC were 2 2 7
differentially associated with inflammatory markers and thus cannot shed any light on whether this markers.
The discrepancies in results between studies might also be because of age, ethnicity, sex, phenotype 2 3 1 or methodological differences. One of the methodological differences that might lead to 2 3 2 discrepancies in the results is the choice measurement sites and the optimal point of measuring SAD 2 3 3 is still debated (3). We used the highest point of the abdomen, which differ from the protocol observing differences between SAD and WC. However, if minor differences in measurement point
can affect the associations drastically, its clinical utility may be limited. Furthermore, it has been 2 3 8
argued that assessment of WC requires less tools and is more practical compared to SAD, which
might limit the use of SAD as a clinical screening tool. However, similarly to others(2) we find that investigator performing the measurement compared to WC.
4 7
One limitation of the present study is the cross-sectional design using biomarkers which is a weaker mortality. Such studies are highly warranted. Furthermore, the present study used individuals, 2 5 0 which were primarily overweight and obese (98%), whereas other studies that used both normal populations. However, our study used a clinically relevant population group, which are at risk of anthropometric measure. The current study has measured many different cardiometabolic outcomes
including markers of insulin resistance, dyslipidemia, low grade inflammation and blood pressure. As previous studies have not included all these markers, this study provides a good view of overall 2 5 7 cardiometabolic health. Furthermore, the sample size in the present study is appropriate to examine In conclusion, the data from 6 cohorts of high-risk individuals showed that neither SAD, WC nor from a public health perspective. 
SAD (cm)
WC ( 
